✦ LIBER ✦

No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan

✍ Scribed by Rue-Tsuan Liu; Yi-Ju Chen; Fong-Fu Chou; Chun-Liang Li; Wei-Li Wu; Po-Chin Tsai; Chao-Cheng Huang; Jiin-Tsuey Cheng

Book ID: 108703267
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 118 KB
Volume: 63
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.2005.02367.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Papillary microcarcinoma in comparison w

Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAFV600E mutation, clinicopathological features, and immunohistochemical findings

✍ Young Joo Park; Young A. Kim; You Jin Lee; Soon Hui Kim; So Yeon Park; Kyung Won 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Abstract ## __Background.__ Papillary thyroid microcarcinoma (PMC; ≤1 cm) is thought to take a benign course during the lifetime. However, recent studies showed high recurrence rates for PMC. ## __Methods.__ We analyzed the clinicopathological features, long‐term prognosis, and some molecular

Clinicopathologic features and BRAFV600E

Clinicopathologic features and BRAFV600E mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas

✍ Lori A. Erickson; Long Jin; Nobuki Nakamura; Alina G. Bridges; Svetomir N. Marko 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 1 views

## Abstract ## BACKGROUND Cutaneous metastases from well‐differentiated thyroid carcinomas are rare and are usually identified in patients with widely disseminated disease. Occasionally, thyroid carcinomas can present as cutaneous metastases for which the primary site needs to be determined. Papil

mRNA BRAF expression helps to identify p

mRNA BRAF expression helps to identify papillary thyroid carcinomas in thyroid nodules independently of the presence of BRAFV600E mutation

✍ Priscila Pereira Costa Araujo; Marjory Alana Marcello; Alfio Jose Tincani; Ana C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 265 KB

BRAF V600E mutation and Its Association

BRAF V600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis

✍ Li, Carol; Lee, Kathleen C.; Schneider, Eric B.; Zeiger, Martha A. 📂 Article 📅 2012 🏛 Endocrine Society 🌐 English ⚖ 661 KB

Clinicopathologic significance of BRAF V

Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid : A meta-analysis

✍ Ju-Han Lee; Eung-Seok Lee; Young-Sik Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

## Abstract ## BACKGROUND. Numerous studies have investigated the clinical significance of __BRAF__ mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on the usefulness of __BRAF__ mutation as a prognostic marker of PTC. To address this controversy, the freque

BRAFV600E mutation and p27kip1 expressio

BRAFV600E mutation and p27kip1 expression in papillary carcinomas of the thyroid ≤1 cm and their paired lymph node metastases

✍ Vito Rodolico; Daniela Cabibi; Giuseppe Pizzolanti; Pierina Richiusa; Nicola Geb 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

## Abstract ## BACKGROUND. __BRAF^V600E^__ mutation and p27^kip1^ expression have been introduced as novel indicators that may predict prognosis in different tumors, as well as in papillary thyroid carcinomas. ## METHODS. Tissue samples from 214 consecutive patients who underwent total or near‐t